WASHINGTON, D.C. – Following today’s issuance by the Centers for Medicare and Medicaid Services (CMS) of a proposed rule on Medicare coverage of innovative technologies, the Advanced Medical Technology Association® (AdvaMed®)…
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker released the following statement: “AdvaMed® fully supports policies that foster innovation and regulatory flexibility to speed quality tests to patients. This principle…
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker released the following statement:
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today issued the following statement from Ashley Wittorf, Executive Director, AdvaMed Accel® & Global Head, Investor Relations, on bipartisan legislation (HR 7917) introduced in the…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests reached approximately 100 million, as of July 25, based on the latest…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests reached approximately 100 million, as of July 25, based on the latest…
WASHINGTON, D.C. – To ensure production of vital medical devices and diagnostic tests during this critical time and to help prevent future supply chain issues, the Advanced Medical Technology Association® (AdvaMed®) announced that…
AdvaMed® announced that shipments of COVID-19 molecular diagnostic tests reached one million per day for the week ending July 24, based on the latest data from the association’s National Testing Registry.
Whitaker Calls National Registry “Crucial Tool” for Federal, State Authorities; Announces More Than 65 Million Tests Shipped Nationwide Since Beginning of Pandemic WASHINGTON, D.C. – In its latest action to help ensure…
WASHINGTON, D.C. – In its latest action to help ensure the widespread availability of testing to detect and contain the coronavirus, the Advanced Medical Technology Association® (AdvaMed®) today announced the creation of…